From 11 to 13 March 2025, Rapid Bio took part in a business mission organized by the Moscow Export Center (MEC) in Azerbaijan, presenting its latest developments in diagnostics and biotechnology.
During the business mission in Baku, 20 leading Moscow‑based innovative companies operating in biotechnology, medicine, energy, and IT showcased their solutions.
Evgeniya Simonova, Project Director at Rapid Bio, delivered a presentation highlighting the company’s advanced, rapid, affordable, and precise diagnostic solutions. She outlined four core development areas:
Special attention was given to the importance of early disease detection for children and the elderly—an international priority for healthcare systems.
While in Azerbaijan, Rapid Bio held meetings with leading medical‑equipment distributors, private clinics, and diagnostic centers, establishing key contacts and discussing pathways to enter the local market.
The mission confirmed strong interest among Azerbaijani partners in Rapid Bio’s innovative solutions, opening prospects for further collaboration and expansion into new markets.
During the business mission in Baku, 20 leading Moscow‑based innovative companies operating in biotechnology, medicine, energy, and IT showcased their solutions.
Evgeniya Simonova, Project Director at Rapid Bio, delivered a presentation highlighting the company’s advanced, rapid, affordable, and precise diagnostic solutions. She outlined four core development areas:
- Lateral flow analysis
- Enzyme‑linked immunosorbent assay (ELISA)
- Next‑generation sequencing (NGS)
- Microfluidics and electrochemistry
Special attention was given to the importance of early disease detection for children and the elderly—an international priority for healthcare systems.
While in Azerbaijan, Rapid Bio held meetings with leading medical‑equipment distributors, private clinics, and diagnostic centers, establishing key contacts and discussing pathways to enter the local market.
The mission confirmed strong interest among Azerbaijani partners in Rapid Bio’s innovative solutions, opening prospects for further collaboration and expansion into new markets.
